Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DAVID F. Archer

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
Contraception|October 20, 2023
Comparison of estrogenic components used for hormonal contraceptionFrank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 23, 2017
Human vaginal pH and microbiota: an updateKeshav Godha, Kelly M Tucker, Colton Biehl, et al.
Menopause (New York, N.Y.)|September 21, 2016
Prescribing of FDA-approved and compounded hormone therapy differs by specialtyGinger D Constantine, David F Archer, Shelli Graham, et al.
Contraception|January 15, 2013
TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studiesTerry A Jacot, Irina Zalenskaya, Christine Mauck, et al.
Menopause (New York, N.Y.)|August 15, 2013
Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination SurveyHind A Beydoun, Rawan el-Amin, Malikah McNeal, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Obstetrics and Gynecology|November 4, 2008
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletJames Simon, Lila Nachtigall, Robert Gut, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 8, 2022
Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestinsShelli Graham, David F Archer, James A Simon, et al.
Fertility and Sterility|July 29, 2009
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenDavid F Archer, Vivian Lewis, Bruce R Carr, et al.
Contraception|October 6, 2012
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrelMarie Foegh, David F Archer, Frank Z Stanczyk, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
Contraception|October 20, 2023
Comparison of estrogenic components used for hormonal contraceptionFrank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 23, 2017
Human vaginal pH and microbiota: an updateKeshav Godha, Kelly M Tucker, Colton Biehl, et al.
Menopause (New York, N.Y.)|September 21, 2016
Prescribing of FDA-approved and compounded hormone therapy differs by specialtyGinger D Constantine, David F Archer, Shelli Graham, et al.
Contraception|January 15, 2013
TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studiesTerry A Jacot, Irina Zalenskaya, Christine Mauck, et al.
Menopause (New York, N.Y.)|August 15, 2013
Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination SurveyHind A Beydoun, Rawan el-Amin, Malikah McNeal, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Obstetrics and Gynecology|November 4, 2008
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletJames Simon, Lila Nachtigall, Robert Gut, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 8, 2022
Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestinsShelli Graham, David F Archer, James A Simon, et al.
Fertility and Sterility|July 29, 2009
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenDavid F Archer, Vivian Lewis, Bruce R Carr, et al.
Contraception|October 6, 2012
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrelMarie Foegh, David F Archer, Frank Z Stanczyk, et al.
Pageof 18